Boston Scientific Corporation (BSX) is an interesting player in the Healthcare space, with a focus on Medical Appliances & Equipment. The stock has been active on the tape, currently trading at $29.43, up from yesterday’s close by 0.65%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.
Money managers are always interested in a company that can find the right recipe of fundamental data because it reflects something important going on underneath the surface. Boston Scientific Corporation (BSX) currently trades with a market capitalization of $40.31 Billion.
The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For BSX, the company currently has $317 Million of cash on the books, which is offset by $1.02 Billion current liabilities. You can get a sense of how sustainable that is by a levered free cash flow of $316 Million over the past twelve months. Generally speaking, earnings are expected to grow in coming quarters. Analysts are forecasting earnings of $0.31 on a per share basis this quarter. Perhaps, that suggests something about why 95.81% of the outstanding share supply is held by institutional investors.
It’s important to check the technicals to get a sense of how BSX has been acting. Looking at the stock’s movement on the chart, Boston Scientific Corporation recorded a 52-week high of $29.50. It is now trading 0.07% off that level. The stock is trading $27.74 its 50-day moving average by -1.69%. The stock carved out a 52-week low down at $19.67.
In recent action, Boston Scientific Corporation (BSX) has made a move of +3.12% over the past month, which has come on weak relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 17.45, and it’s gotten there by action that has been more volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 1.10% with $1.36 Billion sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of BSX.